| Symbol |
Name |
|
AARS
|
alanyl-tRNA synthetase
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACSF3
|
acyl-CoA synthetase family member 3
|
|
ACVR1
|
activin A receptor, type I
|
|
ADA
|
adenosine deaminase
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS17
|
ADAM metallopeptidase with thrombospondin type 1 motif, 17
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPP
|
alkaline phosphatase, placental
|
|
AMN
|
amnion associated transmembrane protein
|
|
ANGPT2
|
angiopoietin 2
|
|
ANOS1
|
anosmin 1
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARID2
|
AT rich interactive domain 2 (ARID, RFX-like)
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKC
|
aurora kinase C
|
|
AUTS2
|
autism susceptibility candidate 2
|
|
AVP
|
arginine vasopressin
|
|
AVPR1B
|
arginine vasopressin receptor 1B
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSG
|
basigin (Ok blood group)
|
|
C11ORF95
|
chromosome 11 open reading frame 95
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCDC28A
|
coiled-coil domain containing 28A
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND2
|
cyclin D2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD320
|
CD320 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD5
|
CD5 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CECR1
|
cat eye syndrome chromosome region, candidate 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFI
|
complement factor I
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CIC
|
capicua transcriptional repressor
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
|
CLCN7
|
chloride channel, voltage-sensitive 7
|
|
CLDN1
|
claudin 1
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
COCH
|
cochlin
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL23A1
|
collagen, type XXIII, alpha 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COLQ
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYGD
|
crystallin, gamma D
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSC
|
cathepsin C
|
|
CTSE
|
cathepsin E
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEL15Q11.2
|
Chromosome 15q11.2 deletion syndrome
|
|
DEL15Q13.3
|
Chromosome 15q13.3 microdeletion syndrome
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DHH
|
desert hedgehog
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DMD
|
dystrophin
|
|
DNM2
|
dynamin 2
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPT
|
dermatopontin
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSC3
|
desmocollin 3
|
|
EDA
|
ectodysplasin A
|
|
EDAR
|
ectodysplasin A receptor
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3M
|
eukaryotic translation initiation factor 3, subunit M
|
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETNK1
|
ethanolamine kinase 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F13B
|
coagulation factor XIII, B polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FAM175A
|
family with sequence similarity 175, member A
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBN1
|
fibrillin 1
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FERMT1
|
fermitin family member 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOXL2
|
forkhead box L2
|
|
FOXP3
|
forkhead box P3
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLIS2
|
GLIS family zinc finger 2
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPC3
|
glypican 3
|
|
GPR101
|
G protein-coupled receptor 101
|
|
GPR148
|
G protein-coupled receptor 148
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H3F3A
|
H3 histone, family 3A
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRG
|
histidine-rich glycoprotein
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFT122
|
intraflagellar transport 122
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL25
|
interleukin 25
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INHA
|
inhibin, alpha
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KCNC1
|
potassium channel, voltage gated Shaw related subfamily C, member 1
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
KDM5D
|
lysine (K)-specific demethylase 5D
|
|
KDR
|
kinase insert domain receptor
|
|
KHDC3L
|
KH domain containing 3-like, subcortical maternal complex member
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KIF21A
|
kinesin family member 21A
|
|
KIF22
|
kinesin family member 22
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT1
|
keratin 1, type II
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT34
|
keratin 34, type I
|
|
KRT4
|
keratin 4, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT86
|
keratin 86, type II
|
|
KRTAP17-1
|
keratin associated protein 17-1
|
|
L1TD1
|
LINE-1 type transposase domain containing 1
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOC647275
|
purine nucleoside phosphorylase pseudogene
|
|
LOR
|
loricrin
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPIN1
|
lipin 1
|
|
LUM
|
lumican
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MATN3
|
matrilin 3
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEAF6
|
MYST/Esa1-associated factor 6
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEST
|
mesoderm specific transcript
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR15B
|
microRNA 15b
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR200A
|
microRNA 200a
|
|
MIR205
|
microRNA 205
|
|
MIR214
|
microRNA 214
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR424
|
microRNA 424
|
|
MIR499A
|
microRNA 499a
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH1
|
mutL homolog 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MSH2
|
mutS homolog 2
|
|
MSH4
|
mutS homolog 4
|
|
MSH6
|
mutS homolog 6
|
|
MT-TK
|
tRNA
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC20
|
mucin 20, cell surface associated
|
|
MVK
|
mevalonate kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO5B
|
myosin VB
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
ND1
|
|
|
NDRG2
|
NDRG family member 2
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NIPAL4
|
NIPA-like domain containing 4
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDZD2
|
PDZ domain containing 2
|
|
PGAM1
|
phosphoglycerate mutase 1 (brain)
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF1
|
PHD finger protein 1
|
|
PHF6
|
PHD finger protein 6
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
PON1
|
paraoxonase 1
|
|
PORCN
|
porcupine homolog (Drosophila)
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDM9
|
PR domain containing 9
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKD1
|
protein kinase D1
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRM2
|
protamine 2
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROK1
|
prokineticin 1
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PROM1
|
prominin 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSG11
|
pregnancy specific beta-1-glycoprotein 11
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTX3
|
pentraxin 3, long
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RANBP2
|
RAN binding protein 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RETN
|
resistin
|
|
RHEBL1
|
Ras homolog enriched in brain like 1
|
|
RHO
|
rhodopsin
|
|
RLN1
|
relaxin 1
|
|
RNF43
|
ring finger protein 43
|
|
RORC
|
RAR-related orphan receptor C
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RPL10
|
ribosomal protein L10
|
|
RPS27
|
ribosomal protein S27
|
|
RSPO2
|
R-spondin 2
|
|
RSPO3
|
R-spondin 3
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
S1PR5
|
sphingosine-1-phosphate receptor 5
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SETD2
|
SET domain containing 2
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SHOX
|
short stature homeobox
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC25A19
|
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19
|
|
SLC26A1
|
solute carrier family 26 (anion exchanger), member 1
|
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLURP1
|
secreted LY6/PLAUR domain containing 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STRN
|
striatin, calmodulin binding protein
|
|
SULF1
|
sulfatase 1
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX21
|
T-box 21
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCN2
|
transcobalamin II
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX40
|
testis expressed 40
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGM5
|
transglutaminase 5
|
|
THBD
|
thrombomodulin
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMC6
|
transmembrane channel-like 6
|
|
TMEM43
|
transmembrane protein 43
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTR
|
transthyretin
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TULP1
|
tubby like protein 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMS
|
thymidylate synthetase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBR1
|
ubiquitin protein ligase E3 component n-recognin 1
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UPK1B
|
uroplakin 1B
|
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae)
|
|
WDR62
|
WD repeat domain 62
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNK2
|
WNK lysine deficient protein kinase 2
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF639
|
zinc finger protein 639
|
